Cargando…
Endothelin-1 in systemic sclerosis
INTRODUCTION: Scleroderma is a systemic disorder with unknown etiology most notably characterized by skin thickening and organ damage. Endothelin-1 (ET-1) plays a role in skin fibrosis. The aim of this study was survey and comparison of ET-1 level in Systemic Sclerosis (SSc) patients with and withou...
Autores principales: | Aghaei, Mehrdad, Gharibdost, Farhad, Zayeni, Habib, Akhlaghi, Maryam, Sedighi, Sima, Rostamian, Abduo Rahman, Aghdami, Naser, Shojaa, Mahdieh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481917/ https://www.ncbi.nlm.nih.gov/pubmed/23130253 http://dx.doi.org/10.4103/2229-5178.93484 |
Ejemplares similares
-
Effects of valproic acid and pioglitazone on cell cycle progression and proliferation of T-cell acute lymphoblastic leukemia Jurkat cells
por: Jazi, Marie Saghaeian, et al.
Publicado: (2016) -
How does endothelial cell injury start? The role of endothelin in systemic sclerosis
por: Abraham, David, et al.
Publicado: (2007) -
Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis
por: Arefiev, Kait, et al.
Publicado: (2011) -
A Phase IV Study of the Safety and Efficacy of CinnoPar(®) in Iranian Patients with Osteoporosis
por: Jamshidi, Ahmadreza, et al.
Publicado: (2021) -
Pulmonary involvement in rheumatoid arthritis: A cross-sectional study in Iran
por: Zayeni, Habib, et al.
Publicado: (2016)